David Holmes has over fifteen years of corporate finance and investor communications experience across multiple healthcare sectors including life science tools, diagnostics and biotechnology companies. David’s in-depth knowledge of investors relations and capital markets has allowed him to successfully structure, build and implement strategic IR and capital advisory programs for oncology, molecular diagnostics and liquid biopsy companies for the last decade.
Prior to joining Gilmartin, David worked at LifeSci Advisors, where he provided both private and public companies strategic IR advice across the medtech, tools and diagnostics industries. Previously, David led investors relations for Rover Diagnostics Inc. and Ascenda BioSciences (formerly Provista Diagnostics, Inc.) running internal IR, corporate messaging and capital markets initiatives.
David began his career at BNP Paribas’ Corporate & Investment Bank where he worked in Structured Credit and Capital Markets originating transactions ranging $100m – $2Bn across multiple industries.
David earned his BA in Economics from St. Lawrence University with a concentration in Econometrics and Modern Game Theory.
Interesting Facts About David
- Learned to fly gliders from Spain’s National Aerobatic Team Champion
- Passionate about supporting State Parks & Land Trusts to preserve open space, wetlands and groundwater for future generations
- Has never had a headache